← FDA DRUG APPROVALS

FDA ANDA · ANDA216795

METRONIDAZOLE VAGINAL GEL

metronidazole vaginal gel, 1.3 %

Sponsor: ENCUBE

APPLICATION
ANDA216795
TYPE
ANDA
ORIGINAL APPROVAL
2024-03-18
LATEST ACTION
2024-03-18
ROUTE
VAGINAL
DOSAGE FORM
GEL
MARKETING STATUS
Discontinued

Products

METRONIDAZOLEDiscontinued
METRONIDAZOLE 1.3% · GEL · VAGINAL

Approval history

2024-03-18UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →